Li et al., recently showed that IMT1(inhibitor of mitochondrial transcription 1), a first-in-class POLRMT inhibitor, robustly inhibited endometrial carcinoma cell growth in vitro and in vivo [22]. This evidence concerns the gene POLRMT and endometrial carcinoma.